N-(6-acetyl-1,3-benzodioxol-5-yl)naphthalene-2-carboxamide | 903354-53-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: N-(6-acetyl-1,3-benzodioxol-5-yl)naphthalene-2-carboxamide
• CAS: 903354-53-0
• 化学式: C₂₀H₁₅NO₄
• 分子量: 333.343
• InChiKey: WNMAWHAQNXTJJI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-(6-acetyl-1,3-benzodioxol-5-yl)naphthalene-2-carboxamide 在 potassium tert-butylate 作用下， 以 甲苯 为溶剂， 反应 72.0h， 以21%的产率得到N-(1,3-benzodioxol-5-yl)naphthalene-2-carboxamide
  参考文献：
  名称：

  Design and Synthesis of 2-(3-Benzo[b]thienyl)-6,7-methylenedioxyquinolin-4-one Analogues as Potent Antitumor Agents that Inhibit Tubulin Assembly

  摘要：

  As part of our continuing investigation of azo-flavonoid derivatives as potential anticancer drug candidates, a series of 2-aryl-6,7-methylenedioxyquinolin-4-one analogues was designed and synthesized. The design combined structural features of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1), a previously discovered compound with potent in vivo antitumor activity, and 2-arylquinolin-4-ones, identified by CoMFA models, The newly synthesized analogues were evaluated for cytotoxicity against seven human cancer cell lines, and structure-activity relationship (SAR) correlations were established. Analogues 1, 37, and 39 showed potent cytotoxicity against different cancer cell lines. Compound I demonstrated selective cytotoxicity against Hep 3B (hepatoma) cells. Compound 37 was cytotoxic against HL-60 (leukemia), HCT-116 (colon cancer), Hep 3B (hepatoma), and SK-MEL-5 (melanoma) cells. Compound 39 exhibited broad cytotoxicity against all seven cancer cell lines, with IC50 values between 0.07and 0.19 mu M. Results from mechanism of action studies revealed that these new quinolone derivatives function as antitubulin agents.

  DOI：

  10.1021/jm900456w
• 作为产物：
  描述：

  2'-氨基-4',5'-亚甲二氧基苯乙酮 、 2-萘甲酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-(6-acetyl-1,3-benzodioxol-5-yl)naphthalene-2-carboxamide
  参考文献：
  名称：

  带有 1,3-苯并二氧杂环戊烷部分的 4-氨基喹啉：作为潜在抗真菌剂的合成和生物学评价

  摘要：

  为了寻找新的环境友好且有效的抗真菌剂，制备了一系列带有 1,3-苯并二氧杂环戊二烯部分的 4-氨基喹啉，并通过光谱分析充分阐明了它们的结构。体外评价了所有目标化合物对五种植物病原真菌的抗真菌活性。结果表明，大多数新合成的化合物在50 μg/mL的浓度下表现出明显的抑制活性。其中，6-（呋喃-2-基） - ñ - （4-甲基苯基）-2 ħ - [1,3]二氧杂环戊烯并[4,5-克]喹啉-8-胺盐酸盐（7米）显示更有前途的抗真菌EC 50值为 10.3 和 14.0 μg/mL 的效力C. lunata和A.分别是交替的。特别是，7m的 EC 50值对C. lunata 的效力是标准嘧菌酯的 7.3 倍。当用50 μg/mL 的7m处理时，C. lunata的菌丝体有一些显着的形态学改变。此外，还讨论了初步的构效关系 (SAR)。因此，这项研究表明，带有 1,3-苯并二氧杂环戊烯部分的 4-氨基喹啉是开发新型抗真菌剂的有趣支架。

  DOI：

  10.1002/cbdv.202100106

文献信息

• 4‐Aminoquinolines Bearing a 1,3‐Benzodioxole Moiety: Synthesis and Biological Evaluation as Potential Antifungal Agents
  作者：Rui Yang、Zhuolin Li、Jialing Xie、Jianchuan Liu、Tianhong Qin、Junda Liu、Haiying Du、Haoyun Ye

  DOI：10.1002/cbdv.202100106

  日期：2021.5

  compounds exhibited obvious inhibitory activities at the concentration of 50 μg/mL. Among them, 6‐(furan‐2‐yl)‐N‐(4‐methylphenyl)‐2H‐[1,3]dioxolo[4,5‐g]quinolin‐8‐amine hydrochloride (7m) displayed more promising antifungal potency with EC50 values of 10.3 and 14.0 μg/mL against C. lunata and A. alternate, respectively. Particularly, the EC50 value of 7m against C. lunata was 7.3‐fold as potent as the standard

  为了寻找新的环境友好且有效的抗真菌剂，制备了一系列带有 1,3-苯并二氧杂环戊二烯部分的 4-氨基喹啉，并通过光谱分析充分阐明了它们的结构。体外评价了所有目标化合物对五种植物病原真菌的抗真菌活性。结果表明，大多数新合成的化合物在50 μg/mL的浓度下表现出明显的抑制活性。其中，6-（呋喃-2-基） - ñ - （4-甲基苯基）-2 ħ - [1,3]二氧杂环戊烯并[4,5-克]喹啉-8-胺盐酸盐（7米）显示更有前途的抗真菌EC 50值为 10.3 和 14.0 μg/mL 的效力C. lunata和A.分别是交替的。特别是，7m的 EC 50值对C. lunata 的效力是标准嘧菌酯的 7.3 倍。当用50 μg/mL 的7m处理时，C. lunata的菌丝体有一些显着的形态学改变。此外，还讨论了初步的构效关系 (SAR)。因此，这项研究表明，带有 1,3-苯并二氧杂环戊烯部分的 4-氨基喹啉是开发新型抗真菌剂的有趣支架。
• Design and Synthesis of 2-(3-Benzo[<i>b</i>]thienyl)-6,7-methylenedioxyquinolin-4-one Analogues as Potent Antitumor Agents that Inhibit Tubulin Assembly
  作者：Yu-Hsun Chang、Mei-Hua Hsu、Sheng-Hung Wang、Li-Jiau Huang、Keduo Qian、Susan L. Morris-Natschke、Ernest Hamel、Sheng-Chu Kuo、Kuo-Hsiung Lee

  DOI：10.1021/jm900456w

  日期：2009.8.13

  As part of our continuing investigation of azo-flavonoid derivatives as potential anticancer drug candidates, a series of 2-aryl-6,7-methylenedioxyquinolin-4-one analogues was designed and synthesized. The design combined structural features of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1), a previously discovered compound with potent in vivo antitumor activity, and 2-arylquinolin-4-ones, identified by CoMFA models, The newly synthesized analogues were evaluated for cytotoxicity against seven human cancer cell lines, and structure-activity relationship (SAR) correlations were established. Analogues 1, 37, and 39 showed potent cytotoxicity against different cancer cell lines. Compound I demonstrated selective cytotoxicity against Hep 3B (hepatoma) cells. Compound 37 was cytotoxic against HL-60 (leukemia), HCT-116 (colon cancer), Hep 3B (hepatoma), and SK-MEL-5 (melanoma) cells. Compound 39 exhibited broad cytotoxicity against all seven cancer cell lines, with IC50 values between 0.07and 0.19 mu M. Results from mechanism of action studies revealed that these new quinolone derivatives function as antitubulin agents.